Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125839111 | 12583911 | 1 | I | 20160711 | 20160722 | 20160722 | EXP | US-UCBSA-2016027462 | UCB | GAJIC O. OMEPRAZOLE: OUTCOME BENEFIT FOR PATIENTS TREATED FOR BLEEDING PEPTIC ULCERS?. CRITICAL CARE. 2000;3(1) | 0.00 | Y | 0.00000 | 20160722 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125839111 | 12583911 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG/DAY | U | U | 75410 | ||||||||
125839111 | 12583911 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Intravenous bolus | 80 MG BOLUS | U | U | 0 | INJECTION | |||||||
125839111 | 12583911 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Intravenous (not otherwise specified) | 8 MG, HOURLY | U | U | 0 | 8 | MG | INJECTION | /hr |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125839111 | 12583911 | 1 | Peptic ulcer |
125839111 | 12583911 | 2 | Peptic ulcer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125839111 | 12583911 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125839111 | 12583911 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |